Log in
NASDAQ:AKTS

Akoustis Technologies Stock Forecast, Price & News

$7.99
-0.04 (-0.50 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$7.77
Now: $7.99
$8.12
50-Day Range
$7.48
MA: $8.04
$8.67
52-Week Range
$3.76
Now: $7.99
$9.55
Volume559,530 shs
Average Volume606,265 shs
Market Capitalization$304.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.65
Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., develops, designs, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industries in the United States. The company operates through two segments, Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment provides engineering review services; and smart systems technology and commercialization center foundry, as well as manufacturing and microelectromechanical systems foundry services. The RF Filters segment consists of amplifier and filter products. It offers RF filters for mobile wireless devices, such as smartphones and tablets, cellular infrastructure equipment, and Wi-Fi premise equipment. The company was founded in 2014 and is headquartered in Huntersville, North Carolina.
Read More
Akoustis Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.50 out of 5 stars


Industry, Sector and Symbol

Industry Telephone & telegraph apparatus
Sub-IndustryN/A
Current SymbolNASDAQ:AKTS
CUSIPN/A
Phone704-997-5735

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.79 million
Book Value$1.14 per share

Profitability

Net Income$-36,140,000.00
Net Margins-2,018.99%

Miscellaneous

Employees69
Market Cap$304.16 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
$7.99
-0.04 (-0.50 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AKTS News and Ratings via Email

Sign-up to receive the latest news and ratings for AKTS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Akoustis Technologies (NASDAQ:AKTS) Frequently Asked Questions

How has Akoustis Technologies' stock price been impacted by Coronavirus (COVID-19)?

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AKTS stock has increased by 50.5% and is now trading at $7.99.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Akoustis Technologies?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Akoustis Technologies
.

When is Akoustis Technologies' next earnings date?

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Akoustis Technologies
.

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies Inc (NASDAQ:AKTS) issued its earnings results on Monday, August, 24th. The technology company reported ($0.27) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.25) by $0.02. The technology company earned $0.37 million during the quarter, compared to analysts' expectations of $0.43 million. Akoustis Technologies had a negative net margin of 2,018.99% and a negative return on equity of 81.49%.
View Akoustis Technologies' earnings history
.

What price target have analysts set for AKTS?

4 brokerages have issued 12 month target prices for Akoustis Technologies' stock. Their forecasts range from $7.00 to $12.00. On average, they anticipate Akoustis Technologies' stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 25.2% from the stock's current price.
View analysts' price targets for Akoustis Technologies
.

Who are some of Akoustis Technologies' key competitors?

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Editas Medicine (EDIT), Marvell Technology Group (MRVL), Alibaba Group (BABA), InVitae (NVTA), Advanced Micro Devices (AMD), JD.Com (JD) and Crispr Therapeutics (CRSP).

Who are Akoustis Technologies' key executives?

Akoustis Technologies' management team includes the following people:
  • Mr. Jeffrey B. Shealy, Founder,Pres, CEO & Director (Age 50)
  • Mr. David M. Aichele, VP of Bus. Devel. (Age 53)
  • Mr. Kenneth Boller, Interim Chief Financial Officer
  • Mr. Thomas Andrew Sepenzis, Director of Investor Relations (Age 47)
  • Mr. Drew Wright, Gen. Counsel & Corp. Sec.

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Who are Akoustis Technologies' major shareholders?

Akoustis Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Handelsbanken Fonder AB (2.10%), UBS Group AG (1.08%), Taylor Frigon Capital Management LLC (1.05%), Rovida Advisors Inc. (1.04%), Commonwealth Equity Services LLC (0.91%) and Mutual of America Capital Management LLC (0.81%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, John T Kurtzweil, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends for Akoustis Technologies
.

Which major investors are selling Akoustis Technologies stock?

AKTS stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Rovida Advisors Inc., Goldman Sachs Group Inc., Financial Advocates Investment Management, Mutual of America Capital Management LLC, Mission Wealth Management LP, and Dorsey & Whitney Trust CO LLC. Company insiders that have sold Akoustis Technologies company stock in the last year include David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, and Steven Denbaars.
View insider buying and selling activity for Akoustis Technologies
.

Which major investors are buying Akoustis Technologies stock?

AKTS stock was purchased by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, EAM Investors LLC, Roubaix Capital LLC, SG Americas Securities LLC, UBS Group AG, Handelsinvest Investeringsforvaltning, Bank of America Corp DE, and California Public Employees Retirement System.
View insider buying and selling activity for Akoustis Technologies
.

How do I buy shares of Akoustis Technologies?

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $7.99.

How big of a company is Akoustis Technologies?

Akoustis Technologies has a market capitalization of $304.16 million and generates $1.79 million in revenue each year. The technology company earns $-36,140,000.00 in net income (profit) each year or ($0.86) on an earnings per share basis. Akoustis Technologies employs 69 workers across the globe.

What is Akoustis Technologies' official website?

The official website for Akoustis Technologies is www.akoustis.com.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at 704-997-5735 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.